Willem Mario Kuhtreiber, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| C-Peptide | 1 | 2015 | 398 | 0.530 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2020 | 346 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2015 | 3244 | 0.250 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2020 | 2938 | 0.160 |
Why?
|
| Deoxyglucose | 1 | 2015 | 348 | 0.140 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 2503 | 0.120 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 4297 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2545 | 0.090 |
Why?
|
| Immunotherapy | 2 | 2020 | 3793 | 0.090 |
Why?
|
| Autoantigens | 1 | 2008 | 914 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8895 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2020 | 1959 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2015 | 6125 | 0.050 |
Why?
|
| Sezary Syndrome | 1 | 2020 | 70 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2020 | 1263 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 4477 | 0.040 |
Why?
|
| Immunoassay | 1 | 2020 | 754 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2020 | 1858 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 21640 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 1746 | 0.040 |
Why?
|
| Prognosis | 1 | 2015 | 28923 | 0.030 |
Why?
|
| Cell Death | 1 | 2020 | 1769 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2020 | 1942 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 17251 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 1992 | 97 | 0.030 |
Why?
|
| Apoptosis | 1 | 2008 | 10261 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 5182 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3881 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 10329 | 0.030 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 1994 | 766 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 59331 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 56052 | 0.020 |
Why?
|
| Child | 1 | 2015 | 71361 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 9114 | 0.020 |
Why?
|
| Adolescent | 1 | 2015 | 84957 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 14656 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 8182 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 1992 | 1401 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11265 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10990 | 0.020 |
Why?
|
| Mice | 2 | 2020 | 80803 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 162271 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21684 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5354 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 211400 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 216468 | 0.010 |
Why?
|
| Humans | 4 | 2020 | 686663 | 0.010 |
Why?
|
| Animals | 4 | 2020 | 170849 | 0.010 |
Why?
|
| Glucose | 1 | 1992 | 4016 | 0.010 |
Why?
|
| Peptides | 1 | 1992 | 4537 | 0.010 |
Why?
|
| Insulin | 2 | 2008 | 6521 | 0.010 |
Why?
|
| Polyvinyl Chloride | 1 | 1994 | 30 | 0.010 |
Why?
|
| Acrylic Resins | 1 | 1994 | 153 | 0.010 |
Why?
|
| Biopolymers | 1 | 1994 | 195 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 60991 | 0.010 |
Why?
|
| Glucagon-Like Peptides | 1 | 1992 | 105 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1994 | 1416 | 0.010 |
Why?
|
| Glucagon | 1 | 1992 | 541 | 0.010 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 1992 | 290 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 2772 | 0.010 |
Why?
|
| Dogs | 1 | 1994 | 4269 | 0.010 |
Why?
|
| Potassium Channels | 1 | 1992 | 573 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1994 | 2159 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1992 | 1242 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1994 | 1240 | 0.010 |
Why?
|
| Rats | 2 | 1994 | 25307 | 0.000 |
Why?
|
| Biocompatible Materials | 1 | 1994 | 1748 | 0.000 |
Why?
|
| Swine | 1 | 1994 | 5441 | 0.000 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 2944 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5167 | 0.000 |
Why?
|
| Models, Biological | 1 | 1992 | 10102 | 0.000 |
Why?
|